Department of Cardiology

The Department of Cardiology (Medizinische Klinik und Poliklinik I) is located at two campuses: Campus Großhadern and Campus Downtown. The department's primary medical focus is on interventional cardiology, which includes cardiac catheterization, coronary intervention, as well as minimally invasive procedures for repairing the aortic (TAVI), mitral, and tricuspid valves.

In terms of research, the Department of Cardiology is dedicated to basic and translational cardiovascular research. Specifically, the              department conducts research on the role of innate immune cells and platelet regulatory molecules in thrombosis, as well as the mechanisms underlying ischemia/reperfusion injury. The department also conducts large-scale clinical trials to test the efficacy of cardiovascular interventions and novel treatment regimens, bridging the gap between research and clinical practice.

Moreover, the Department of Cardiology is a member of the German Center for Cardiovascular Research (DZHK) and the Munich Heart Alliance (MHA), and participates in several Collaborative Research Centers funded by the German Research Foundation (DFG), focusing on immune cell trafficking (CRC 914), atherosclerosis (CRC 1123), neutrophil biology (CRC TR332), and neonatal immunology (CRC TR359). Additionally, researchers from Medical Department 1 receive funding from various sources, such as the European Research Council (ERC), the transatlantic Leducq consortium on clonal hematopoiesis in atherosclerosis, the Else Kröner-Fresenius-Stiftung, and others.

Further information on the working groups can be found here (currently only available in German):                                                                            Medizinische Klinik und Poliklinik I | Forschung und Lehre